NutriBand (NTRB) Operating Income (2016 - 2026)
NutriBand (NTRB) posted Operating Income of -$1.3 million for Q2 2026, down 22.87% sequentially from -$1.0 million in Q1 2026, and up 11.26% YoY from -$1.1 million in Q2 2025.
NutriBand (NTRB) Operating Income (2016 - 2026) Analysis & Trends
NutriBand has reported Operating Income for 11 years, with the latest figure at -$1.3 million in Q2 2026.
- Quarterly Operating Income rose 11.26% year-over-year to -$1.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$8.2 million (up 16.82% YoY) and the FY2026 annual result came in at -$8.3 million, up 19.12% from the prior year.
- Operating Income slipped to -$1.3 million in Q2 2026 per NTRB's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Operating Income peaked at -$685879.0 in Q2 2022 and troughed at -$5.6 million in Q1 2025.
- A 5-year average of -$1.8 million and a median of -$1.4 million in 2024 frame the typical range for Operating Income.
- The sharpest annual moves came in 2025 and 2026: Operating Income tumbled 325.52% in 2025, then soared 81.63% in 2026.
- Over 5 years, Operating Income stood at -$1.1 million in 2022, then sank by 60.85% to -$1.7 million in 2023, then climbed by 17.21% to -$1.4 million in 2024, then sank by 171.95% to -$3.9 million in 2025, then jumped by 67.67% to -$1.3 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$1.3 million, -$1.0 million, and -$3.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 133.12 Mn |
| 10 | NutriBand | 48.38 Mn | 44.37 Mn | 196,801.00 | -1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.25 Mn |
| Jan 31, 2026 | -1.02 Mn |
| Oct 31, 2025 | -3.88 Mn |
| Jul 31, 2025 | -2.00 Mn |
| Apr 30, 2025 | -1.41 Mn |
| Jan 31, 2025 | -5.56 Mn |
| Oct 31, 2024 | -1.43 Mn |
| Jul 31, 2024 | -1.41 Mn |
| Apr 30, 2024 | -1.89 Mn |
| Jan 31, 2024 | -1.31 Mn |
| Oct 31, 2023 | -1.72 Mn |
| Jul 31, 2023 | -824,188.00 |
| Apr 30, 2023 | -1.02 Mn |
| Jan 31, 2023 | -1.68 Mn |
| Oct 31, 2022 | -1.07 Mn |
| Jul 31, 2022 | -1.03 Mn |
| Apr 30, 2022 | -685,879.00 |
| Jan 31, 2022 | -3.78 Mn |
| Oct 31, 2021 | -1.54 Mn |
| Jul 31, 2021 | -482,242.00 |